drugset / Trial / NCT02113072

Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.

NCT02113072

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate whether Probiotics promote reduction of recurrent wheezing in infants, stimulating the immune system to Th1 response.

Timeline

Start
2014-04
Primary completion
2014-08
Completion
2014-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Probiotics Other / unclassified 1 g Oral
Background Beclomethasone Small molecule 50 ug Inhaled

Indications